DE602007009199D1 - Verfahren zur bestimmung pseudoallergischer reaktionen - Google Patents

Verfahren zur bestimmung pseudoallergischer reaktionen

Info

Publication number
DE602007009199D1
DE602007009199D1 DE602007009199T DE602007009199T DE602007009199D1 DE 602007009199 D1 DE602007009199 D1 DE 602007009199D1 DE 602007009199 T DE602007009199 T DE 602007009199T DE 602007009199 T DE602007009199 T DE 602007009199T DE 602007009199 D1 DE602007009199 D1 DE 602007009199D1
Authority
DE
Germany
Prior art keywords
determining
patient
reactions
compound
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007009199T
Other languages
English (en)
Inventor
Xavier Fouillet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco Suisse SA
Original Assignee
Bracco Suisse SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Suisse SA filed Critical Bracco Suisse SA
Publication of DE602007009199D1 publication Critical patent/DE602007009199D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Testing Of Optical Devices Or Fibers (AREA)
  • Eye Examination Apparatus (AREA)
DE602007009199T 2006-02-16 2007-02-05 Verfahren zur bestimmung pseudoallergischer reaktionen Active DE602007009199D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06110056 2006-02-16
PCT/EP2007/051078 WO2007093517A1 (en) 2006-02-16 2007-02-05 Method to determine pseudo-allergic reactions

Publications (1)

Publication Number Publication Date
DE602007009199D1 true DE602007009199D1 (de) 2010-10-28

Family

ID=36102858

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007009199T Active DE602007009199D1 (de) 2006-02-16 2007-02-05 Verfahren zur bestimmung pseudoallergischer reaktionen

Country Status (5)

Country Link
US (1) US20090017475A1 (de)
EP (1) EP1991868B1 (de)
AT (1) ATE481636T1 (de)
DE (1) DE602007009199D1 (de)
WO (1) WO2007093517A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2037269B1 (de) * 2007-09-11 2014-04-02 Bühlmann Laboratories AG Allergietest auf Basis durchflusszytometrischer Analysen
WO2018199840A1 (en) * 2017-04-25 2018-11-01 Russom Amam Microfluidic method and system for detecting basophil aller-gen threshold sensitivity (cd-sens) by using a gradient of at least one allergen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2765341A1 (fr) * 1997-06-25 1998-12-31 Alain Funes Methode pour l'analyse de l'activation des basophiles humains par mesure de l'expression membranaire du marqueur cd63
CZ292686B6 (cs) * 2001-09-17 2003-11-12 Imumed S. R. O. Způsob měření aktivace basofilů po stimulaci alergenem pro stanovení přecitlivělosti na tento alergen a příslušný kit
WO2005041756A2 (en) * 2003-10-27 2005-05-12 Healthaide, Inc. Skin test for detecting non-allergic hypersensitivity

Also Published As

Publication number Publication date
ATE481636T1 (de) 2010-10-15
EP1991868A1 (de) 2008-11-19
EP1991868B1 (de) 2010-09-15
WO2007093517A1 (en) 2007-08-23
US20090017475A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
WO2007071963A3 (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
TW200634003A (en) Chemical compounds
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
TW200621259A (en) Chemical compounds
WO2009088838A3 (en) Triarylmethane analogs and their use in treating cancers
CY1111159T1 (el) Πυκνα διαλυματα μεθοτρεξατης
BRPI0514691A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
ATE539757T1 (de) Verfahren zur hemmung von nkt-zellen
HUP0301749A2 (hu) Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
WO2007113558A8 (en) Quinazolinone derivatives having b-raf inhibitory activity
MY142067A (en) Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease
CY1111433T1 (el) Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης
BRPI0517458A (pt) derivados da xantina com atividade para o receptor hm74a
ECSP088974A (es) Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3)
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
SE0400234D0 (sv) New compounds, methods for their preparation and use thereof
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
DK1727817T3 (da) Azabicyclooctan-3-onderivativer og anvendelse heraf
ATE516366T1 (de) Regulierte aptamer-therapeutika
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
ATE481636T1 (de) Verfahren zur bestimmung pseudoallergischer reaktionen